We're hiring!
Stämm is a biotechnology company where engineering, chemistry, biology, and software development teams (among many others) work side by side.
We have the pace of a startup, the rigor of R&D, and an interdisciplinary, problem-solving-focused environment.
Translating deep novel tech into decentralized biomanufacturing requires understanding both the molecular level and the global scale. Our Chief Strategy Officer, Faith Wallace-Gadsden, has spent her career building global public health ventures.
At BioSpain, she will be discussing how our High-Throughput Bioprocesor gives R&D teams ultra-low shear stress and continuous perfusion for biologics production with adherent or suspension cell cultures. Contact her or find her on the floor.
Román Ortega Bianchi, Head of Business Development de Stämm, va a integrar el panel sobre cooperación suizo-argentina junto a Dante Paz (CONICET) y Thiago Cruz Silveira (Greater Geneva Bern area (GGBa)).
Contarán qué implica desarrollar y vender hardware de bioprocesamiento desde Buenos Aires hacia Europa y Estados Unidos.
También estarán en el escenario María Friedrich (ETH Entrepreneurship) y María Eugenia Barcos (Nestlé).
Nos vemos el 17 de septiembre en el Planetario.
Where do you think your cells would rather live?
Option A: A turbulence-ridden Erlenmeyer flask full of their debris and metabolic products.
Option B: A laminar-flow, bubble-free, gyroid-based bioreactor with no shear stress and fresh media.
We're hiring!
Stämm is a biotechnology company where engineering, chemistry, biology, and software development teams (among many others) work side by side.
We have the pace of a startup, the rigor of R&D, and an interdisciplinary, problem-solving-focused environment.
All positions are 100% on-site in the Autonomous City of Buenos Aires (Retiro).
If you see yourself in any of these roles, apply via the link below.
If this might help someone you know, here’s the easiest favor you’ll do this week: share this post or forward it to them.
Basic science asks "why?" Industry asks "now what?"
Our cell culture specialist made that jump, from an immunology PhD to building Stämm's first producer cell line.
More than 50 people stopped at the booth daily. Some came back a second time. A few came back a third just to watch the HTB run again: continuous perfusion, bubble-free, laminar flow, in hardware instead of on a slide.
The full account of the four days is in the new article.
PhD life: defend one hypothesis for years. Startup life: test five, kill what doesn't work by Friday.
Our cell culture expert Mariángeles made that jump, from tumor biology research to biomanufacturing
Ask her what a bioreactor actually is and she skips the jargon: "It produces biomass, but also bioproducts, the antibody or inhibitor a cell makes. You purify it, and you've got your therapy."
Full interview: linkedin.com/pulse/from-lab-…